Trial Profile
VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Fracture
- Focus Therapeutic Use
- Acronyms VITAL
- 07 Aug 2023 Planned End Date changed from 1 Jun 2023 to 1 Aug 2024.
- 07 Aug 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Aug 2024.
- 28 Jul 2022 Primary endpoint (Incident total, non-vertebral, and hip fractures) has not been met, as per published in the New England Journal of Medicine.